Status:
COMPLETED
Dose Response of Fractional Exhaled Nitric Oxide (FeNO) to Inhaled Steroids in Mild-to-moderate Asthma
Lead Sponsor:
University of Dundee
Conditions:
Asthma
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Asthma is a chronic disease, which means that it cannot be cured, but the investigators can use inhalers and tablets to control the symptoms. In asthma, the airways become inflamed and irritated which...
Eligibility Criteria
Inclusion
- Diagnosis os asthma, taking 200-1000mcg budesonide or equivalent per day
- FENO greater than 30ppb on treatment
Exclusion
- Recent RTI or prednisolone
- Smoking within 1 year or 10 pack years
- ABPA, COPD, bronchiectasis
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00995657
Start Date
October 1 2009
End Date
December 1 2011
Last Update
April 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asthma and Allergy Research Group, University of Dundee
Dundee, Tayside, United Kingdom, DD1 9SY